Nancy Wysenski insider trades
Open-market stock purchases and sales by Nancy Wysenski, Director at Cytokinetics Inc, from SEC Form 4 filings since Jul 14, 2010.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +61%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 16, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | $6.2K |
| Jul 15, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | $6.2K |
| May 27, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | — |
| May 27, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | — |
| Apr 15, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | $6.2K |
| Jan 15, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | $6.2K |
Companies traded
- CYTK Cytokinetics Inc: other filings, last Oct 16, 2026
- ALKS Alkermes plc.: 3 buys, 1 sale, last Jul 7, 2023
- PRVB Provention Bio, Inc: other filings, last Apr 27, 2023
- DOVA Dova Pharmaceuticals Inc: other filings, last Nov 12, 2019
- TTPH Tetraphase Pharmaceuticals Inc: other filings, last Jun 10, 2019
- INO Inovio Pharmaceuticals, Inc: other filings, last May 13, 2016
- VRTX Vertex Pharmaceuticals Inc / MA: 11 sales, last May 14, 2012